Haemonetics Corporation is engaged in developing and manufacturing blood processing technology that help ensures a safe and adequate blood supply. The Company is engaged in manufacturing automated systems and single use consumables used in blood donation, blood processing, and surgical salvage of blood. Its direct customers are blood and plasma collectors, hospitals and hospital service providers. Haemonetics Corporation markets devices and related consumables, information technology platforms, and consulting services. The Company manages three global product families: Donor, which markets blood and plasma collection devices, consumables and other business solutions; Patient, which markets into hospitals surgical blood salvage and blood demand diagnostic devices and consumables, as well as blood management services, and Software/Services, which markets information technology platforms and consulting services to blood and plasma collectors and hospitals.